After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Tenaya Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Tenaya Therapeutics Inc is $115.66M. A total of 1.92 million shares were traded on the day, compared to an average of 4.82M shares.
In the most recent transaction, Saito Chihiro sold 2,258 shares of TNYA for 2.12 per share on Nov 18 ’24. After the transaction, the SVP, Accounting and Fin. Ops. now owns 60,983 company shares. In a previous transaction on Aug 16 ’24, Saito Chihiro sold 2,363 shares at 2.89 per share. TNYA shares that SVP, Accounting and Fin. Ops. owns now total 63,241.
Among the insiders who sold shares, Tingley Whittemore disposed of 7,428 shares on Aug 16 ’24 at a per-share price of $2.89. This resulted in the Chief Medical Officer holding 107,106 shares of TNYA after the transaction. In another insider transaction, Ali Faraz sold 9,748 shares at $2.89 per share on Aug 16 ’24. Company shares held by the Chief Executive Officer now total 188,331.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TNYA has a high of $7.01 and a low of $0.99.
As of this writing, TNYA has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.28 per share and a lower estimate of -$0.35.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TNYA’s latest balance sheet shows that the firm has $251.30M in Cash & Short Term Investments as of fiscal 2021. There were $15.70M in debt and $21.77M in liabilities at the time. Its Book Value Per Share was $1.42, while its Total Shareholder’s Equity was $278.53M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TNYA is Buy with a score of 5.00.
